Clinical Trial Update: Efficacy Study on Trabectedin in Retroperitoneal Leiomyosarcoma and Well Differentiated/Dedifferentiated Liposarcoma [Phase 2]

View source ↗

Summary

Phase 2 trial update on trabectedin for liposarcoma and leiomyosarcoma completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leiomyosarcoma
• Liposarcoma

Drugs mentioned

• Trabectedin (trabectedin)

Snippet

Sponsor: Italian Sarcoma Group | Conditions: Liposarcoma, Leiomyosarcoma | Phase 2 | Status: COMPLETED